ENDRA Life Sciences
NDRA
4 hedge funds and large institutions have $720 invested in ENDRA Life Sciences in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 8 closing their positions.
0.01% less ownership
Funds ownership: 0.03% → 0.02% (-0.01%)
56% less funds holding
Funds holding: 9 → 4 (-5)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
98% less capital invested
Capital invested by funds: $32.9K → $720 (-$32.2K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$633 |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$27 |
| 3 |
DB
Danske Bank
Copenhagen K,
Denmark
|
+$20 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$16K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$3.86K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.28K |
| 4 |
Two Sigma Investments
New York
|
-$2.85K |
| 5 |
Jane Street
New York
|
-$2.25K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $595 | +$633 | +95 | New |
|
2
Morgan Stanley
New York
| $81 | -$413 | -62 | -83% |
|
|
3
Bank of America
Charlotte,
North Carolina
| $25 | +$27 | +4 | New |
|
|
DB
4
Danske Bank
Copenhagen K,
Denmark
| $19 | +$20 | +3 | New |
|
|
VF
5
Virtu Financial
New York
| – | -$16K | -2,300 | Closed |
|
|
TSS
6
Two Sigma Securities
New York
| – | -$3.86K | -549 | Closed |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| – | -$3.28K | -466 | Closed |
|
|
8
Two Sigma Investments
New York
| – | -$2.85K | -405 | Closed |
|
|
HF
9
HRT Financial
New York
| – | -$2K | -396 | Closed |
|
|
10
Jane Street
New York
| – | -$2.25K | -320 | Closed |
|
|
JF
11
Jump Financial
Chicago,
Illinois
| – | -$2.05K | -291 | Closed |
|
|
NA
12
NewEdge Advisors
New Orleans,
Louisiana
| – | -$113 | -20 | Closed |
|
NDRA Hedge Fund Activity: Q4 2024 in Review
4 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q4 2024, worth a combined $720 — down 98% from $32.9K a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of NDRA and 3 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was UBS Group, opening a new position worth an estimated $633. The largest seller was Virtu Financial, exiting entirely with an estimated $16K sold.
- 4 institutional investors held ENDRA Life Sciences (NDRA) as of Q4 2024, down from 9 in Q3 2024.
- Funds reported $720 of ENDRA Life Sciences stock for Q4 2024, down 98% quarter-over-quarter.
- 3 funds opened new ENDRA Life Sciences positions in Q4 2024 and 8 closed out, a net change of -5 holders.
- The largest ENDRA Life Sciences buyer in Q4 2024 was UBS Group, an estimated $633 added.
- The largest ENDRA Life Sciences seller in Q4 2024 was Virtu Financial, an estimated $16K sold.
Based on aggregated 13F filings for Q4 2024.